BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 23263457)

  • 1. Molecular interaction fields vs. quantum-mechanical-based descriptors in the modelling of lipophilicity of platinum(IV) complexes.
    Ermondi G; Caron G; Ravera M; Gabano E; Bianco S; Platts JA; Osella D
    Dalton Trans; 2013 Mar; 42(10):3482-9. PubMed ID: 23263457
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Tsipis AC; Karapetsas IN
    Magn Reson Chem; 2017 Jul; 55(7):662-669. PubMed ID: 28002879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New 7-azaindole palladium and platinum complexes: crystal structures and theoretical calculations. In vitro anticancer activity of the platinum compounds.
    Ruiz J; Rodríguez V; de Haro C; Espinosa A; Pérez J; Janiak C
    Dalton Trans; 2010 Apr; 39(13):3290-301. PubMed ID: 20449459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calculation of lipophilicity of a large, diverse dataset of anticancer platinum complexes and the relation to cellular uptake.
    Oldfield SP; Hall MD; Platts JA
    J Med Chem; 2007 Oct; 50(21):5227-37. PubMed ID: 17900102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiproliferative activity of a series of cisplatin-based Pt(IV)-acetylamido/carboxylato prodrugs.
    Ravera M; Gabano E; Zanellato I; Fregonese F; Pelosi G; Platts JA; Osella D
    Dalton Trans; 2016 Mar; 45(12):5300-9. PubMed ID: 26903367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, characterization, in vitro antitumoral investigations and interaction with plasmid pBR322 DNA of R2eddp-platinum(IV) complexes (R = Et, n-Pr).
    Kaluderović GN; Kommera H; Schwieger S; Paethanom A; Kunze M; Schmidt H; Paschke R; Steinborn D
    Dalton Trans; 2009 Dec; (48):10720-6. PubMed ID: 20023900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel dinuclear platinum(II) complexes containing mixed nitrogen-sulfur donor ligands.
    Hochreuther S; Puchta R; van Eldik R
    Inorg Chem; 2011 Dec; 50(24):12747-61. PubMed ID: 22085155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The preparation and characterization of trans-platinum(IV) complexes with unusually high cytotoxicity.
    Cubo L; Hambley TW; Sanz Miguel PJ; Carnero A; Navarro-Ranninger C; Quiroga AG
    Dalton Trans; 2011 Jan; 40(2):344-7. PubMed ID: 20936210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and in vitro anticancer activity of octahedral platinum(IV) complexes with cyclohexyl-functionalized ethylenediamine-N,N'-diacetate-type ligands.
    Lazić JM; Vucićević L; Grgurić-Sipka S; Janjetović K; Kaluderović GN; Misirkić M; Gruden-Pavlović M; Popadić D; Paschke R; Trajković V; Sabo TJ
    ChemMedChem; 2010 Jun; 5(6):881-9. PubMed ID: 20408161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative structure-activity relationship of organophosphate compounds based on molecular interaction fields descriptors.
    Zhao J; Yu S
    Environ Toxicol Pharmacol; 2013 Mar; 35(2):228-34. PubMed ID: 23348103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rhenium(I) and platinum(II) complexes with diimine ligands bearing acidic phenol substituents: hydrogen-bonding, acid-base chemistry and optical properties.
    Liu W; Heinze K
    Dalton Trans; 2010 Oct; 39(40):9554-64. PubMed ID: 20820607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding trans platinum complexes as potential antitumor drugs beyond targeting DNA.
    Quiroga AG
    J Inorg Biochem; 2012 Sep; 114():106-12. PubMed ID: 22819649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What do we know about the reduction of Pt(IV) pro-drugs?
    Wexselblatt E; Gibson D
    J Inorg Biochem; 2012 Dec; 117():220-9. PubMed ID: 22877926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.
    Siddik ZH; al-Baker S; Thai G; Khokhar AR
    Anticancer Drug Des; 1994 Apr; 9(2):139-51. PubMed ID: 8166929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the many roles of NH3 ligands in mono- and multinuclear complexes of platinum.
    Sanz Miguel PJ; Roitzsch M; Yin L; Lax PM; Holland L; Krizanovic O; Lutterbeck M; Schürmann M; Fusch EC; Lippert B
    Dalton Trans; 2009 Dec; (48):10774-86. PubMed ID: 20023907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noncovalent interactions between a trinuclear monofunctional platinum complex and human serum albumin.
    Wang Y; Wang X; Wang J; Zhao Y; He W; Guo Z
    Inorg Chem; 2011 Dec; 50(24):12661-8. PubMed ID: 22077361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decomposition of Intermolecular Interactions in the Crystal Structure of Some Diacetyl Platinum(II) Complexes: Combined Hirshfeld, AIM, and NBO Analyses.
    Soliman SM; Barakat A
    Molecules; 2016 Dec; 21(12):. PubMed ID: 27929446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantum chemical topology study of the water-platinum(II) interaction.
    Bergès J; Fourré I; Pilmé J; Kozelka J
    Inorg Chem; 2013 Feb; 52(3):1217-27. PubMed ID: 23347164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemistry and biological activity of platinum amidine complexes.
    Michelin RA; Sgarbossa P; Sbovata SM; Gandin V; Marzano C; Bertani R
    ChemMedChem; 2011 Jul; 6(7):1172-83. PubMed ID: 21630470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. QSAR modelling of bioconcentration factor using hydrophobicity, hydrogen bonding and topological descriptors.
    Dearden JC; Hewitt M
    SAR QSAR Environ Res; 2010 Oct; 21(7-8):671-80. PubMed ID: 21120755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.